NDC 59572-102-01
VIDAZA 100 mg/1
azacitidine · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
VIDAZA is a injection, powder, lyophilized, for solution containing azacitidine at a strength of 100 mg/1. Manufactured by Celgene Corporation.
Key Facts
- Brand Name
- VIDAZA
- Generic Name
- azacitidine
- NDC Code (Package)
59572-102-01- NDC Code (Product)
59572-102- Manufacturer
- Celgene Corporation
- Strength
- 100 mg/1
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Marketing Status
- Application #
- NDA050794
- Drug Class
- Nucleoside Metabolic Inhibitor [EPC]
- Marketing Start
- 07/05/2004
Recall History
No Recall HistoryView Full Drug Page
VIDAZA — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.